Metatech (ap) Inc. · TPEX:3224
Metatech (ap) — Earnings Presentation (December 2025)
27 slides from Metatech (ap)'s earnings presentation, Dec 16, 2025
Slide 1: METATECH (AP) INC. Investor Conference
Stock Code 3224 METATECH (AP) INC. Investor Conference 2025/12/16
Slide 2: Disclaimer
Disclaimer The contents of this presentation and related information are the information collected by the company from various prior documents. The Company is dedicated to the future development. The actual results of operations, financial condition and business achievement may differ from the forec
Slide 3: Governance Evaluation Score Distribution of OTC Company
Governance Evaluation Score Distribution of OTC Company Stable Corporate Governance Evaluation Result Scale Year 3
Slide 4: Presentation Outline
1 Electronics Division Status and Future Market Strategy 簡報 大綱 2 Biomedical Division Status and Technical Development 3 Biomedical Digitalization Strategy
Slide 5: Electronics Division Status and Future Market Strategy
01. Electronics Division Status and Future Market Strategy AI Market Applications and Strategic Goals
Slide 6: Electronics Department Performance 2016-2025 Q3
Electronics Department Performance 2016-2025 Q3 Revenue Performance Unit: NT$ Thousands Unit: NT$ Thousands Year Year 6
Slide 7: AI Server Applications
AI Server Applications AI Server Market Size, by Processor Type, 2020~2030(USD Billion) The Company continues to deploy in the Artificial Intelligence (AI) server field. Our products are primarily applied to the high-speed transmission and connection requirements of AI servers, covering two major ca
Slide 8: AI Power Supply Applications
AI Power Supply Applications Power Supply Units (PSU) Market Market Size in USD Billion The Company continues to deploy in the AI power supply market. Market Growth and Scale Our agency products primarily target High Voltage and High Current applications, covering connectors and cables. As power dem
Slide 9: Semiconductor Market Applications
Semiconductor Market Applications Co-Packaged Optics(CPO) Market In the semiconductor market, the Company's products are mainly Size 2025 to 2034 (USD Million) applied in CPC (Co-Packaged Copper) and CPO (Co-Packaged Optics) architectures for high-speed Market Growth and Scale transmission7 solution
Slide 10: Revenue Share by Market Segment
Revenue Share by Market Segment Estimated Revenue Share Growth for 2026 8% 23.3% AI Power Supply AI Servers Revenue proportion (%) 1.3% 2025 Full Year Semiconductor Estimate approx Market NTD 1.5 Billion AI Servers Semiconductor AI Power Market Supply 10
Slide 11: Biomedical Division Status and Technical Development
02. Biomedical Division Status and Technical Development
Slide 12: Biomedical Division Revenue Continues Significant Growth
Biomedical Division Revenue Continues Significant Growth 84% MetaTech partners with Hannah Quinlivan to promote the growth vs 2024 future of health, welcoming the launch of Taiwan's 'Dual Regenerative Medicine Laws' and leading the new trend of family iPSC banking 122% Revenue Growth (%) growth vs 2
Slide 13: Number of Partner Institutions Continues to Grow
Number of Partner Institutions Continues to Grow Partner Clinics 71 Clinics (Covering northern, central, and southern regions) 20 Number of Partner Clinics 38 • Cell Authentication Clinics: 7+ 4 Clinics • Regulations of Special Medical Techniques approved Institutions: 12 Clinics • iPSC Partner Clin
Slide 14: Taiwan's Regenerative Medicine Act — Launching a New Era of Cell Therapy
Taiwan's Regenerative Medicine Act — Launching a New Era of Cell Therapy 2026: Regenerative Medicine Act officially • Regenerative Medicinal Products Act: Strengthening GMP standards to ensure safety and consistency of cell preparations. launches, injecting new momentum into • MetaTech is the first
Slide 15: MetaTech Leverages Dual Regenerative Medicine Laws to Showcase Core Competence
MetaTech Leverages Dual Regenerative Medicine Laws to Showcase Core Competence Regenerative Regenerative Medicine Regenerative Medicine Laws: Legal Highlights MetaTech Group Advantages Medicine Act Production Regulations Cell Operation Regulations and Taiwan's First PIC/S GMP Cell Preparation Pilot
Slide 16: Personalized Precision Medicine—Starting with iPSC Banking
Personalized Precision Medicine—Starting with iPSC (Induced Pluripotent Stem Cells) Banking 2014 (USA): CIRM established, iPSC public 2013 (South Korea): South Korean banking with approximately government established iPSC 2,000 lines public banking with approximately 100 lines. • 2024: Build Taiwan'
Slide 17: Diverse Development of iPSC Banking
Diverse Development of iPSC Banking: A New Plan for the Next Generation of Cell Therapy METATECH GROUP iPSC Banking Brain Heart Services • Personalized Family Health Cell Bank iPSC • Drug Screening Platform Induced Pluripotent Stem Cells • Seeds for Personalized Precision Lungs Cell Therapies: Liver
Slide 18: Clinical Trial Progress
Clinical Trial Progress Cell-Therapy Product Indication Phase 2025 2026 2027 Autologous Oral Esophageal Approval III Clinical Trial Ongoing Review Inspection Registration Application Epithelial Cells Cancer Allogeneic Kidney IND CDE IND preparation Complete Preclinical Testing Consultation Submissio
Slide 19: Biomedical Digitalization Strategy
03. Biomedical Digitalization Strategy From Data to Decision: How ICT and AI Realize the Smart Upgrade of Regenerative Medicine Manufacturing
Slide 20: MetaTech Group Digital Transformation Strategy
MetaTech Group Digital Transformation Strategy Upgrade and Transform Cross-Domain Integration Creating Win-Win Digitization + Automation + Intelligence Biotech + ICT + Medical Engineering MetaTech Group + Domestic Strategic Technology Partners + International Strategic Partners Near Term Mid Term Lo
Slide 21: PIC/S GMP Cell Factory Experience
PIC/S GMP Cell Factory Experience MetaTech has accumulated a vast amount of GMP documentation 6 Years 3 11 experience and GMP GTP massive documentation Assessments passed Inspections passed One cell product line requires over 1,000 GMP documents 21
Slide 22: NEOKATANA - AI GMP Document Generation System
NEOKATANA™- AI GMP Document Generation System BEFORE Multiple personnel across multiple departments required to draft a single document NEOKATANA-AI GMP Document Generation System AFTER One person, one computer, one-click document generation (Shortens R&D time, reduces costs) 22
Slide 23: Benefits of NEOKATANA
Benefits of NEOKATANA ™ Based on approx. 1,220 quality Unit：hr documents at MetaTech's Xizhi plant 43.8% 1 2 1 author reviewer approver Document Review Approval Creation Pure Manual NEOKATANA Assisted 23
Slide 24: MetaTech & CM Plus Jointly Build Cross-National GMP AI Document Platform
MetaTech & CM Plus Jointly Build Cross-National GMP AI Document Platform 《The Globe and Mail》reported on the partnership Taiwan-Japan Major Collaboration: MetaTech and CM Plus Sign MOU to Jointly Build 'AI Katana' Biotech Platform MetaTech combines with CM Plus to transform physical experience into
Slide 25: MetaTech Smart Factory Holds Multiple Patents
MetaTech Smart Factory Holds Multiple Patents Total Patent Applications 36 cases （30 invention patents, 6 utility patents） • Invention Patents 30 cases • Utility Patents 6 cases • Approved Patents 10 cases Statistics cutoff date: December 9, 2025 25
Slide 26: Taiwan Regenerative Medicine Act — Launching a New Era of Cell Therapy
Taiwan Regenerative Medicine Act — Launching a New Era of Cell Therapy AI + Regenerative Medicine PIC/S GMP Cell Preparation Pilot Plant Cell Storage: Certification The "Seeds" of Cell Therapy Metatech Is Ready To Embrace The Generation Of Personalized Precision Regenerative Medicine 26
Slide 27: THANK YOU
THANK YOU Listening Your Feedback is Highly Appreciated Stock Code 3224
Metatech (AP) — Earnings Presentation (December 2025) on 6ix